5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | NEUTRAL | BUY | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.35▲ | 2.35▼ | 2.35▼ | 2.33▲ | 2.37▼ |
MA10 | 2.35▲ | 2.36▼ | 2.34▲ | 2.34▲ | 2.39▼ |
MA20 | 2.35▼ | 2.34▲ | 2.34▲ | 2.41▼ | 2.71▼ |
MA50 | 2.35▲ | 2.33▲ | 2.30▲ | 2.44▼ | 5.41▼ |
MA100 | 2.34▲ | 2.31▲ | 2.39▼ | 2.83▼ | N/A |
MA200 | 2.30▲ | 2.40▼ | 2.42▼ | 4.54▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.001▼ | -0.001▼ | 0.002▲ | -0.006▼ | 0.241▲ |
RSI | 48.000▼ | 53.830▲ | 55.203▲ | 45.684▼ | 27.051▼ |
STOCH | 44.444 | 25.957 | 57.971 | 35.522 | 29.330 |
WILL %R | -50.000 | -47.826 | -47.826 | -58.345 | -75.410▼ |
CCI | 24.779 | 4.656 | 44.206 | -17.720 | -71.249 |
Thursday, June 26, 2025 05:00 PM
Get the latest YieldMax MRNA Option Income Strategy ETF (MRNY) stock news and headlines to help you in your trading and investing decisions.
|
Thursday, June 26, 2025 03:00 PM
Moderna, Inc. (NASDAQ:MRNA), a key player in the biotechnology and healthcare sector, operates within the broader framework of the Nasdaq Composite.
|
Tuesday, June 24, 2025 12:09 PM
Moderna Inc. (NASDAQ:MRNA) is one of the best mid cap growth stocks to invest in now. On June 12, the US FDA expanded the approval for Moderna’s respiratory syncytial virus/RSV vaccine, mRESVIA ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
30/06/25 | 2.39 | 2.415 | 2.33 | 2.35 | 1,556,900 |
27/06/25 | 2.36 | 2.37 | 2.29 | 2.30 | 1,716,965 |
26/06/25 | 2.32 | 2.37 | 2.32 | 2.35 | 1,276,545 |
25/06/25 | 2.30 | 2.32 | 2.28 | 2.31 | 1,477,966 |
24/06/25 | 2.27 | 2.33 | 2.26 | 2.32 | 2,259,600 |
23/06/25 | 2.23 | 2.26 | 2.20 | 2.25 | 3,657,500 |
20/06/25 | 2.25 | 2.25 | 2.21 | 2.25 | 2,843,300 |
18/06/25 | 2.43 | 2.43 | 2.37 | 2.39 | 5,961,100 |
17/06/25 | 2.42 | 2.475 | 2.40 | 2.42 | 1,656,500 |
16/06/25 | 2.48 | 2.49 | 2.393 | 2.43 | 1,405,500 |
|
|
||||
|
|
||||
|
|